A randomized controlled trial in healthy participants to compare the insulinogenic effects of whey protein and pea protein co-ingested with glucose.
- 2026-01-30
- PloS one 21(1)
- Pariyarath Sangeetha Thondre
- Elysia Young
- Sam Pledger
- Sarah Kefyalew
- Isabel Hatami
- Caroline Perreau
- Laetitia Guérin Deremaux
- Catherine Lefranc-Millot
- Jonathan Tammam
- PubMed: 41615946
- DOI: 10.1371/journal.pone.0340386
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Population
- 30 healthy individuals
- Methods
- single-blind, randomised, crossover study compared the effects of co-ingesting glucose with 10 or 20 g whey protein and glucose with 10 or 20 g pea protein, with a reference product (glucose)
- Blinding
- Single-blind
- Funding
- Unclear
Research Insights
Glucose incremental area under the curve (mmol/l*min) at 180 minutes was significantly reduced (p < 0.001) for glucose with 20 g pea protein (89.8 ± 51.6) ... compared to glucose (143.2 ± 74.0).
- Effect
- Beneficial
- Effect size
- Large
- Dose
- 20 g
Insulin incremental area under the curve at 180 minutes (µU/ml*min) for glucose with 20 g pea protein (4304.56 ± 1896.07) was significantly lower (p < 0.001) than glucose with 20g whey protein (6311.81 ± 3489.12).
- Effect
- Beneficial
- Effect size
- Large
- Dose
- 20 g
Insulin incremental area under the curve at 180 minutes (µU/ml*min) for glucose with 20 g pea protein (4304.56 ± 1896.07) was significantly lower (p < 0.001) than glucose with 20g whey protein (6311.81 ± 3489.12).
- Effect
- Harmful
- Effect size
- Large
- Dose
- 20 g
Glucose incremental area under the curve (mmol/l*min) at 180 minutes was significantly reduced (p < 0.001) for glucose with 20 g pea protein (89.8 ± 51.6) ... compared to glucose (143.2 ± 74.0).
- Effect
- Beneficial
- Effect size
- Large
- Dose
- 20 g